Growth hormone therapy with norditropin (somatropin ) in growth hormone deficiency

Bibliography

• Symposium Proceedings, based on presentation by. Rosenfeld R, Allen DB, McGillivary MH, et al. Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders. Am J Manag Care 2000;6(Suppl 15):S805-16
   Google Scholar
• Drake WM, Howell SJ, Monson JP, et al. Optimizing GH therapy in adults and children. Endocr Rev 2001;22:425-50
   PubMed Web of Science ®Google Scholar
• Root AW, Root MJ. Clinical pharmacology of human growth hormone and its secretagouges. Curr Drug Targets Immune Endocr Metab Dosord 2002;2:27-52
   PubMedGoogle Scholar
• Root AW, Diamond FB. Regulation and clinical assessment of growth hormone secretion. Endocrine 2000;12(2):137-45
   PubMed Web of Science ®Google Scholar
• Wilson TA, Rose SR, Cohen P, et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutic Committee. J Pediatr 2003;143(4):415-21
   PubMed Web of Science ®Google Scholar
• Contant R, Ronleau S, Despert F, et al. Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. J Clin Endocrinol Metab 2001;86:4649-54
   PubMed Web of Science ®Google Scholar
• Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hipopituitary Study Group. Lancet 2001;357:425-31
   PubMed Web of Science ®Google Scholar
• Koranyi J, Svensson J, Gotherstrom G, et al. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood onset: a comparative, prospective study. J Clin Endocrinol Metab 2001;86:4693-9
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Committee on Drugs and Committee on Bioethics. Consideration related to the use of recombinant human growth hormone in children. Pediatrics 1997;99(1):122-9
   PubMedGoogle Scholar
• Tanner JM, Whitehouse RH. Growth response in 26 children with short stature given growth hormone. Br Med J 1967;2:69-75
   PubMed Web of Science ®Google Scholar
• Laron Z, Bauman B, Josefsberg Z. Importance of age at initiation of hGH therapy. In: laron Z, Butenandt O, Raiti S. eds. Clinical use of growth hormone treatment: influence on final height. Acta Paediatr Scand Suppl 1987;337:4-11
   PubMedGoogle Scholar
• Vanderschueren-Lodeweyckx M, Van den Broeck J, Walter R, et al. Early initiation of growth hormone treatment influence on final height. Acta Paediatr Scand Suppl 1987;337:4-11
   PubMedGoogle Scholar
• Guyda H, Dean H. Intermittent vs continuous GH administration in growth hormone deficiency. In: Laron Z, Butenandt O, Raitis, editors. Clinical use of growth hormone. Present and future aspects. Volume 16 S Krager AG; New York, NY; 1987. p. 61-71
   Google Scholar
• Smith PJ, Hindmarsh PC, Brook CG. Contribution of dose and frequency of administration to the therapeutic affect of growth hormone. Arch Dis Child 1988;63:491-4
   PubMed Web of Science ®Google Scholar
• Attanasio AF, Lamberts SWJ, Mattanga AMC. Adult growth hormone (GH) deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab 1997;82:82-8
   PubMed Web of Science ®Google Scholar
• Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-8
   PubMed Web of Science ®Google Scholar
• Rates AS, Van't Hoff W, Jones PJ, et al. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996;81:1169-72
   PubMed Web of Science ®Google Scholar
• Binnerts A, Deurenberg P, Swart GR, et al. Body composition in growth hormone-deficient adults. Am J Clin Nutr 1992;55:918-23
   PubMed Web of Science ®Google Scholar
• Rosen T, Johannson G, Hallgren P, et al. Beneficial effects of 12 months replacement therapy with recombinant human growth hormone in growth hormone deficient adults. Endocrinol Metab 1994;1:55-66
   Google Scholar
• MacGillivray MH, Baptista J, Johanson A. Outcome of a four-year randomized study of daily versus three times weekly somatotropin treatment in prepubertal naïve growth hormone-deficient children. Genentech Study Group. J Clin Endocrinol Metab 1996;81:1806-9
   PubMed Web of Science ®Google Scholar
• Blethen SL, Baptista J, Kuntze J, et al. Adult height in growth hormone (GH)- deficient children treated with biosynthetic GH. The Genentech Growth Study Group. J Clin Endocrinol Metab 1997;82:418-20
   PubMed Web of Science ®Google Scholar
• August GP, Julius JR, Blethen SL. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone. The National Cooperative Growth Study Experience. Pediatrics 1998;102:512-16
   PubMed Web of Science ®Google Scholar
• MacGillivray MH, Blethen SL, Buchlis JG, et al. Current dosing of growth hormone in children with growth hormone deficiency: how physiologic? Pediatrics 1998;108:527-30
   Google Scholar
• Norditropin somatropin (rDNA origin) injection, prescribing information, version 14, May 25. 2011
   Google Scholar
• Pawlikowska-Haddal A, Cohen P, Cook DM. How useful are serum IGF-I measurements for managing GH therapy in adults and children. Pituitary 2011; [Epub ahead of print]
   Web of Science ®Google Scholar
• Ross J, Lee P, Karwe V, et al. Treatment response to growth hormone therapy (GHT) in children with short stature and different diagnoses: data from the ANSWER Program. Poster Presentation [P1-726]; 2009
   Google Scholar
• Muller J, Skakkebaek NE, Jacobsen BB, et al. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device. Horm Res 1999;51(Suppl 3):109-12
   PubMedGoogle Scholar
• Drent ML, Jakobsdottir S, van Wijk JAE, et al. Acceptability of liquid human growth hormone (hGH) [Norditropin SimpleXx®] in adults and children with chronic renal disease. Clin Drug Investig 2002;22(9):633-8
   PubMed Web of Science ®Google Scholar
• Schoning Fuchs G, Mikkelsen S, Knudsen TK, et al. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open label, uncontrolled usability test. Clin Ther 2009;31:2906-14
   PubMed Web of Science ®Google Scholar
• Dumas H, Panayiotopoulos P, Parker D, et al. Understanding and meeting the needs of those using growth hormone injection devices. BMC Endocr Disord 2006;6:5
   PubMedGoogle Scholar